Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients

World Journal of Gastroenterology

Volumn 15, Issue 6, 2009, Pages 753-755

  Pastor, Rebecca ^a   Habersetzer, François ^c   Fafi Kremer, Samira ^a,b,d   Doffoël, Michel ^c   Baumert, Thomas F ^b,c,d   Gut, Jean Pierre ^a,b,d   Stoll Keller, Françoise ^a,b,d   Schvoerer, Evelyne ^a,b,d  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b INSERM   (France)

^c HÔPITAL CIVIL   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Hepatitis B virus; Treatment naive patients; Viral polymerase mutations

Indexed keywords

ADEFOVIR; TENOFOVIR; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE; VIRUS PROTEIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC DISEASE; DRUG INDICATION; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; MIDDLE AGED;

ADENINE; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENETIC VARIATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; VIRAL PROTEINS;

EID: 65649147137     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.753     Document Type: Article

References (16)

1. Pallier C, Castéra L, Soulier A, Hézode C, Nordmann P, Dhumeaux D, Pawlotsky JM. Dynamics of hepatitis B virus resistance to lamivudine. J Virol 2006; 80: 643-653
2. Durantel D, Brunelle MN, Gros E, Carrouée-Durantel S, Pichoud C, Villet S, Trepo C, Zoulim F. Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing. J Clin Virol 2005; 34 Suppl 1: S34-S43
3. Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. J Hepatol 2007; 47: 366-372
4. Delaney WE, Ray AS, Yang H, Qi X, Xiong S, Zhu Y, Miller MD. Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus. Antimicrob Agents Chemother 2006; 50: 2471-2477
5. Wai CT, Fontana RJ. Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liver Dis 2004; 8: 321-352, vi
6. Bartholomeusz A, Locarnini S. Hepatitis B virus mutations associated with antiviral therapy. J Med Virol 2006; 78 Suppl 1: S52-S55
7. Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Plym M, Pokornowski K, Yu CF, Angus P, Ayres A, Bartholomeusz A, Sievert W, Thompson G, Warner N, Locarnini S, Colonno RJ. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother 2004; 48: 3498-3507
8. Borroto-Esoda K, Miller MD, Arterburn S. Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. J Hepatol 2007; 47: 492-498
9. Chen CH, Wang JH, Lee CM, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS. Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil. Antivir Ther 2006; 11: 771-778
10. Schildgen O, Sirma H, Funk A, Olotu C, Wend UC, Hartmann H, Helm M, Rockstroh JK, Willems WR, Will H, Gerlich WH. Variant of hepatitis B virus with primary resistance to adefovir. N Engl J Med 2006; 354: 1807-1812
11. Yamazhan T, Sertöz R, Pullukçu H, Taşbakan M, Ulusoy S, Erensoy S. [A case of chronic hepatitis B with primary adefovir resistance] Mikrobiyol Bul 2007; 41: 297-301
12. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol 2009; 50: 227-242
13. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 Suppl 1: S1-S3
14. Shaw T, Bartholomeusz A, Locarnini S. HBV drug resistance: mechanisms, detection and interpretation. J Hepatol 2006; 44: 593-606
15. Sheldon J, Camino N, Rodés B, Bartholomeusz A, Kuiper M, Tacke F, Núñez M, Mauss S, Lutz T, Klausen G, Locarnini S, Soriano V. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther 2005; 10: 727-734
16. Wu GY, Chen HS. Novel approaches towards conquering hepatitis B virus infection. World J Gastroenterol 2007; 13: 830-836